FAIRFIELD, N.J., March 3 /PRNewswire-FirstCall/ -- Bradley
Pharmaceuticals, Inc. (NYSE: BDY) today announced that it will participate in
the Raymond James 27th Annual Institutional Investors Conference, March 5-8,
2006 at the Hyatt Regency Grand Cypress in Orlando, FL.
Daniel Glassman, President and CEO, is scheduled to present on Tuesday,
March 7, 2006 beginning at 11:35 AM (ET). Mr. Glassman will discuss the
Company's financial and business performance and expectations.
A live audio webcast of Mr. Glassman's presentation can be accessed by
visiting http://www.wsw.com/webcast/rj19/bdy/
Please visit Bradley Pharmaceuticals web site at:
http://www.bradpharm.com
Bradley Pharmaceuticals common stock is listed on the NYSE under the
symbol BDY.
Bradley Pharmaceuticals, Inc. (NYSE: BDY) was founded in 1985 as a
specialty pharmaceutical company and markets to niche physician specialties in
the U.S. and 38 international markets. Bradley's success is based on the
strategy of Acquire, Enhance and Grow. Bradley Acquires non-strategic brands,
Enhances these brands with line extensions and improved formulations and Grows
the products through promotion, advertising and selling activities to optimize
life cycle management. Bradley Pharmaceuticals is comprised of Doak
Dermatologics, specializing in topical therapies for dermatology and podiatry;
Kenwood Therapeutics, providing gastroenterology, respiratory and other
internal medicine brands; and A. Aarons, which will market authorized generic
versions of Doak and Kenwood therapies.
Important announcement:
Doak Dermatologics continues its dedicated support of the American Academy
of Dermatology that dates to the organization's inception. Doak will be an
Emerald sponsor of the 64th Annual Meeting of the AAD, to be held in San
Francisco, CA, March 3-7, 2006.
Daniel Glassman will present the POLYPHENON(R) E Ointment agreement at an
Investor Conference while at the AAD meeting in San Francisco, CA, March 3,
2006.
Daniel Glassman will present at the Raymond James & Associates 27th Annual
Institutional Investors Conference, Hyatt Regency Grand Cypress in Orlando,
FL, March 7, 2006.
Daniel Glassman will present at the CIBC World Markets Annual Specialty
Pharmaceutical & Biotechnology Conference, to be held at the Millennium
Broadway Hotel in New York City, April 4-5, 2006.
Daniel Glassman will present at the Banc of America Securities LLC, Health
Care Conference 2006, to be held at The Four Seasons Hotel in Las Vegas, NV,
May 16-18, 2006.
Daniel Glassman will present a case study on Optimizing Lifecycle
Management for a Product with Limited Patent Protection at the MedAd News'
Specialty Pharmaceuticals Summit, June 6-8, 2006 at 8:45 a.m. at the Park
Hyatt, Philadelphia, PA.
SOURCE Bradley Pharmaceuticals, Inc.
 back to top
Related links:
http://www.bradpharm.com
http://www.wsw.com/webcast/rj19/bdy
CONTACT:
Anthony Griffo, Investor Relations of Bradley
Pharmaceuticals, Inc., +1-973-882-1505, ext. 313
|
